BDSX
Biodesix, Inc.
BDSX
Biodesix, Inc.
Biodesix is gaining momentum in lung diagnostics, with >30% revenue growth and accelerating test volumes. BDSX boasts 80%+ gross margins and improving operating leverage, supporting a credible path to
Biodesix, Inc. (BDSX) Q2 2026 Earnings Call Transcript